Cited by 51Artificial Intelligence in Healthcare and EducationMachine Learning in HealthcareInformation Retrieval and Search Behavior

Answering real-world clinical questions using large language model, retrieval-augmented generation, and agentic systems

Open access
Low, Yen Sia, Jackson, Michael L, Hyde, Rebecca J, Brown, Robert E, Sanghavi, Neil M, Baldwin, Julian D, Pike, C William, Muralidharan, Jananee +19 more·2025·DIGITAL HEALTH

Abstract

Objective: The practice of evidence-based medicine can be challenging when relevant data are lacking or difficult to contextualize for a specific patient. Large language models (LLMs) could potentially address both challenges by summarizing published literature or generating new studies using real-world data. Materials and Methods: We submitted 50 clinical questions to five LLM-based systems: OpenEvidence, which uses an LLM for retrieval-augmented generation (RAG); ChatRWD, which uses an LLM as an interface to a data extraction and analysis pipeline; and three general-purpose LLMs (ChatGPT-4, Claude 3 Opus, Gemini 1.5 Pro). Nine independent physicians evaluated the answers for relevance, quality of supporting evidence, and actionability (i.e., sufficient to justify or change clinical practice). Results: General-purpose LLMs rarely produced relevant, evidence-based answers (2–10% of questions). In contrast, RAG-based and agentic LLM systems, respectively, produced relevant, evidence-based answers for 24% (OpenEvidence) to 58% (ChatRWD) of questions. OpenEvidence produced actionable results for 48% of questions with existing evidence, compared to 37% for ChatRWD and <5% for the general-purpose LLMs. ChatRWD provided actionable results for 52% of questions that lacked existing literature compared to <10% for other LLMs. Discussion: Special-purpose LLM systems greatly outperformed general-purpose LLMs in producing answers to clinical questions. Retrieval-augmented generation-based LLM (OpenEvidence) performed well when existing data were available, while only the agentic ChatRWD was able to provide actionable answers when preexisting studies were lacking. Conclusion: Synergistic systems combining RAG-based evidence summarization and agentic generation of novel evidence could improve the availability of pertinent evidence for patient care.

AI snapshot

Written from the paper’s full text.

TL;DR

In a 50-question evaluation, purpose-built LLM systems outperformed general-purpose LLMs for clinical questions, with ChatRWD and OpenEvidence producing more relevant, evidence-based, and actionable answers. ChatRWD was especially stronger on novel questions lacking published literature, while OpenEvidence performed better when existing evidence was available.

Key findings

  • Relevant, evidence-based answers were produced for 24% of questions by OpenEvidence and 58% by ChatRWD, versus 2–10% for ChatGPT-4, Claude 3 Opus, and Gemini 1.5 Pro (p < 0.0001).
  • Overall actionability was 30% for OpenEvidence and 44% for ChatRWD, compared with 2–4% for general-purpose LLMs; combined OpenEvidence plus ChatRWD reached 60% actionable and 66% relevant/evidence-based.
  • On novel questions, ChatRWD produced actionable answers for 52.2% and relevant/evidence-based answers for 65.2%, while OpenEvidence produced 8.7% for both.
  • General-purpose LLMs frequently hallucinated or included irrelevant citations: citation errors were found in 40–80% of relevant answers; over 40% of Claude and Gemini citations and 25.5% of ChatGPT citations could not be located on PubMed.

Methods

  • Fifty clinical questions were submitted to five LLM-based systems: OpenEvidence (RAG), ChatRWD (agentic RWD/causal inference), ChatGPT-4, Claude 3 Opus, and Gemini 1.5 Pro.
  • Nine independent physicians graded responses for relevance, evidence quality, and actionability using a standardized rubric; citation validity was checked for systems providing citations, and ChatRWD’s phenotypes/TQL code underwent study integrity review by two medical informaticists.
  • Ratings were aggregated by majority vote into response categories; success proportions were compared using chi-square and Fisher exact tests with Holm–Bonferroni correction, and inter-rater reliability was assessed with Fleiss’ Kappa.

Limitations

  • The authors state that questions were restricted to those potentially answerable with RWD, cohort study designs, and existing phenotypes; reviewers could not be blinded to model identity; novelty rates may differ elsewhere; inter-rater reliability was only fair for core measures; domain-specific finetuned LLMs were not tested; ChatRWD used a single US data source; and general-purpose LLMs received a generic prompt without iterative reprompting.
  • The text also makes evident that the specific percentages may shift with different reviewers or question sets, and that the non-blinded design could not control for reviewer preference for a given model.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1177/20552076251348850

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 27 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    OpenEvidence produced actionable results for 48% of questions with existing evidence.

    “OpenEvidence produced actionable results for 48% of questions with existing evidence, compared to 37% for ChatRWD and <5% for the general-purpose LLMs.”
    Quote in the paperSubstantial claim
  • Findingown data

    Other LLMs provided actionable results for <10% of questions that lacked existing literature.

    “ChatRWD provided actionable results for 52% of questions that lacked existing literature compared to <10% for other LLMs.”
    Quote in the paperSubstantial claim
  • Findingown data

    ChatRWD provided actionable results for 52% of questions that lacked existing literature.

    “ChatRWD provided actionable results for 52% of questions that lacked existing literature compared to <10% for other LLMs.”
    Quote in the paperSubstantial claim
  • Findingown data

    OpenEvidence produced relevant, evidence-based answers for 24% of questions.

    “RAG-based and agentic LLM systems, respectively, produced relevant, evidence-based answers for 24% (OpenEvidence) to 58% (ChatRWD) of questions.”
    • Also stated in: § Relevance, evidence, and actionability · plain
      “The physician reviewers found that OpenEvidence and ChatRWD produced relevant, evidence-based answers for 24% and 58% of the questions, respectively.”
    Quote in the paperSubstantial claim
  • Findingown data

    General-purpose LLMs rarely produced relevant, evidence-based answers, meeting this standard for 2-10% of questions.

    “General-purpose LLMs rarely produced relevant, evidence-based answers (2–10% of questions).”
    • Also stated in: § Relevance, evidence, and actionability · plain
      “For comparison, the physician reviewers rarely judged answers from the general-purpose LLMs to be relevant and evidence-based, meeting this standard for 2–10% of the responses.”
    Quote in the paperSubstantial claim
  • May combine two claims. 22
  • Classified as probably not a substantial claim. 28
  • May combine two claims.

    Findingown data

    When reviewers decided which answer was best, ChatRWD was the most common choice on 60% of questions, followed by OpenEvidence (46%).

    “When reviewers decided which answer was the best, ChatRWD was the most common choice on 60% of the questions, followed by OpenEvidence (46%) (Table 2).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    For actionability, reviewers rarely found LLM answers (2-4%) actionable, while OpenEvidence (30%) and ChatRWD (44%) were more often judged actionable.

    “For the stricter criterion of actionability, where the reviewers judged the answers to be of sufficient quality to justify or change clinical practice, the reviewers rarely found the LLM answers (2–4%) to be actionable, while answers from OpenEvidence (30%) and ChatRWD (44%) were more often judged to be actionable (Table 2).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    ChatRWD and OpenEvidence each significantly outperformed the general-purpose LLMs in actionability (p < 0.009 for all).

    “This pattern of differences was also statistically significant (p < 0.0001 by chi-square test); ChatRWD and OpenEvidence each significantly outperformed the general-purpose LLMs in pairwise comparisons (p < 0.009 for all) but were not significantly different from each other (p = 0.21) (Supplemental Table 5).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    OpenEvidence significantly outperformed Gemini in relevant, evidence-based answers (p = 0.011) but not ChatGPT-4 or Claude.

    “In pairwise comparisons, ChatRWD's rate of relevant, evidence-based answers was significantly higher than the general-purpose LLMs (p < 0.0001 by Fisher exact test for all comparisons) and OpenEvidence (p = 0.007); OpenEvidence significantly outperformed Gemini (p = 0.011) but not the other models (Supplemental Table 5).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    OpenEvidence and ChatRWD produced answers for 86% and 94% of questions, respectively.

    “The RAG and agentic systems produced answers for 86% (OpenEvidence) and 94% (ChatRWD) of the questions (Table 1, Supplemental Figure 2), compared to 58–78% of questions in the three general-purpose LLMs (Supplemental Table 3) used for benchmarking.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Inter-rater reliability across the key metrics was fair to moderate, with Fleiss' Kappa of 0.38 for actionability, 0.31 for best answer, and 0.56 for response categories.

    “Inter-rater reliability across the key metrics was found to be fair to moderate (Supplemental Table 8): Fleiss’ Kappa statistics of 0.38 and 0.31 (fair) for actionability and best answer, respectively, and 0.56 (moderate) for response categories.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    OpenEvidence rarely misinterpreted the questions and did not hallucinate citations.

    “Of note, OpenEvidence rarely misinterpreted the questions and did not hallucinate citations.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Over 40% of all citations from Claude and Gemini could not be located on PubMed, as well as 25.5% of ChatGPT's citations.

    “Over 40% of all citations from Claude and Gemini could not be located on PubMed, as well as 25.5% of ChatGPT's citations (Supplemental Table 6).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    ChatRWD was more likely to generate answers of varying quality while OpenEvidence would, at worst, provide partially relevant and partially evidence-based answers.

    “ChatRWD was more likely to generate answers of varying quality while OpenEvidence would, at worst, provide partially relevant and partially evidence-based answers (Figure 2, Table 4, Supplemental Figure 3).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In combination, OpenEvidence and ChatRWD provided relevant, evidence-based answers to 66% of the questions and were deemed actionable 60% of the time.

    “In combination, these two tools provided relevant, evidence-based answers to 66% of the questions and were deemed actionable 60% of the time.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    ChatRWD misspecification usually stemmed from ill-defined phenotypes and sometimes from logical errors.

    “Misspecification by ChatRWD usually stemmed from ill-defined phenotypes and sometimes from logical errors (e.g., misinterpreting “and” for “or” logic in drug combinations).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    On questions with existing literature, OpenEvidence produced relevant and evidence-based answers 37% and actionable answers 48.2%, while ChatRWD produced relevant and evidence-based answers 51.9% and actionable answers 37.0%.

    “Conversely, on questions that have existing literature, the comparative gap narrowed (37% relevant and evidence-based, 48.2% actionable by OpenEvidence vs. 51.9% relevant and evidence-based, 37.0% actionable by ChatRWD).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Large language models are prone to hallucinating reference materials or treatment guidelines and may produce recommendations that are satirical, inappropriate, or misaligned with evidence-based guidelines.

    “However, they are prone to hallucinating reference materials or treatment guidelines17,18 and may produce “recommendations” that are satirical, inappropriate, 19 or misaligned with evidence-based guidelines. 20”
    Quote in the paperSubstantial claim0 of 4 sources checked
    • cites [17] Chelli M Descamps J Lavoué V, et al. Hallucination rates and reference accuracy of ChatGPT and bard for systematic reviews: comparative analysis. J Med Internet Res 2024; 26: e53164. PMC11153973 38776130 source

      Not checked in the free run.

    • cites [18] Kumar M Mani UA Tripathi P, et al. Artificial hallucinations by google bard: think before you leap. Cureus 2023; 15: e43313. PMC10492900 37700993

      Not checked in the free run.

    • cites [19] Minsberg T. Google Is Using A.I. to Answer Your Health Questions. Should You Trust It? The New York Times [Internet]. 2024 [cited 2024 Jun 20], https://www.nytimes.com/2024/05/31/well/live/google-ai-health-information.html?unlocked_article_code=1.wE0.RlP-.GwjhpTQbUHjH&smid=nytcore-ios-share&referringSource=articleShare&u2g=c

      Not checked in the free run.

    • cites [20] Nwachukwu BU Varady NH Allen AA, et al. Currently available large language models do not provide musculoskeletal treatment recommendations that are concordant with evidence-based clinical practice guidelines. Arthroscopy 2024: 263–275. 39173690

      Not checked in the free run.

  • May combine two claims.

    Study design and conductreasoning

    ChatRWD was allowed access to a single data source from the United States due to data rights considerations, and results may be different if evaluated using other RWD sources, including data from another country.

    “ChatRWD was allowed access to a single data source from the United States due to data rights considerations, and results may be different if evaluated using other RWD sources, including data from another country.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    The study did not consider domain-specific LLMs finetuned on medical knowledge which may fare better than the general LLMs used.

    “Also, we did not consider domain-specific LLMs finetuned on medical knowledge which may fare better than the general LLMs we used. 35”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [35] Li J Deng Y Sun Q, et al. Benchmarking large language models in evidence-based medicine. IEEE J Biomed Health Inform 2024: PP. DOI: 10.1109/JBHI.2024.3483816. 39437276 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Inter-rater agreement on response category, best model, and actionable metrics was calculated using Fleiss' Kappa.

    “We calculated the inter-rater agreement on response category, best model, and actionable metrics using Fleiss’ Kappa. 30”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [30] Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull 1971; 76: 378– 382. source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    The phenotype definitions are curated by physicians and subject matter experts; where possible, definitions are sourced from published frameworks such as the Observational Health Data Sciences and Informatics initiative.

    “The definitions are curated by physicians and subject matter experts; where possible, definitions are sourced from published frameworks such as the Observational Health Data Sciences and Informatics initiative.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    ChatRWD uses an interactive interface to help correct the inferred PICO and phenotypes.

    “This contrasts with ChatRWD, which uses an interactive interface to help correct the inferred PICO and phenotypes (Supplemental Figure 1).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationreasoning

    Optimizing the prompt for each model could potentially improve the performance of these systems.

    “Optimizing the prompt for each model could potentially improve the performance of these systems.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    The phenotypes were scrutinized to ensure there were no inappropriate inclusions or omissions in order to accurately answer the research question.

    “The phenotypes were scrutinized to ensure there were no inappropriate inclusions or omissions in order to accurately answer the research question.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given

    The phenotype library defines nearly 2000 diseases and conditions based on procedure codes, diagnosis codes, medication prescriptions, and/or laboratory tests and results.

    “The phenotype library defines nearly 2000 diseases and conditions based on procedure codes, diagnosis codes, medication prescriptions, and/or laboratory tests and results.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    LLMs hallucinate and use noncredible sources.

    “First, LLMs hallucinate 31 and use noncredible sources.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [31] Chen S Guevara M Moningi S, et al. The effect of using a large language model to respond to patient messages. Lancet Digit Health 2024; 6: e379– e381. PMC11829255 38664108

      Not checked in the free run.

  • Classified as probably not a substantial claim. May combine two claims.

    Premisereasoning

    ChatRWD does not return citations because the study is run on-demand using RWD.

    “ChatRWD does not return citations because the study is run on-demand using RWD.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    An analysis focused on different types of questions, such as listing drug-drug interactions, could give different results.

    “An analysis focused on different types of questions, such as listing drug–drug interactions, could give different results.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The general-purpose LLMs were prompted using a standard but generic prompt.

    “First, these models were prompted using a standard but generic prompt.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    Questions were submitted to the general-purpose LLMs programmatically without any iterative revision.

    “Second, questions were submitted to the general-purpose LLMs programmatically without any iterative revision.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    None of the reviewers were employees of either Atropos Health or OpenEvidence.

    “None of the reviewers were employees of either Atropos Health or OpenEvidence.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    The core of ChatRWD is an advanced cohorting engine for selecting patients and data coupled with a causal inference engine for automated statistical analysis.

    “The core of ChatRWD is an advanced cohorting engine for selecting patients and data 29 coupled with a causal inference engine for automated statistical analysis. 8”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [29] Callahan A Polony V Posada JD, et al. ACE: the advanced cohort engine for searching longitudinal patient records. J Am Med Inform Assoc 2021; 28: 1468– 1479. 33712854 PMC8279796 source

      Not checked in the free run.

    • cites [8] Callahan A Gombar S Cahan EM, et al. Using aggregate patient data at the bedside via an on-demand consultation service. NEJM Catal 2021; 2. DOI: 10.1056/CAT.21.0224. source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Clinicians struggle to find relevant and high-quality evidence for such real-world patients, so studies have to be performed on demand.

    “It is precisely because clinicians struggle to find relevant and high-quality evidence for such real-world patients that studies have to be performed on demand. 34”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [34] Schuler A Callahan A Jung K, et al. Performing an informatics consult: methods and challenges. J Am Coll Radiol 2018; 15: 563– 568. 29396125 PMC5901653 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    ChatRWD involves rule-based generation of TQL code defining a study cohort.

    “ChatRWD involves rule-based generation of TQL code 29 defining a study cohort.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [29] Callahan A Polony V Posada JD, et al. ACE: the advanced cohort engine for searching longitudinal patient records. J Am Med Inform Assoc 2021; 28: 1468– 1479. 33712854 PMC8279796 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    It is possible that reprompting the general-purpose LLMs could improve their performance.

    “However, it is possible that reprompting the general-purpose LLMs could improve their performance.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    The physicians reviewed the content independently and were not able to see the responses of their peers.

    “The physicians reviewed the content independently and were not able to see the responses of their peers.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationown data

    There is a need to rapidly conduct new studies on demand.

    “Given that almost half of our selected questions were novel at the time of this study, there is a need to rapidly conduct new studies on demand.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: These new studies are motivated by patients with specific preexisting conditions and medications who do not qualify for clinical trials.
  • Classified as probably not a substantial claim.

    Study design and conductown data

    Ratings from the nine clinical reviewers were aggregated based on a majority vote.

    “We first aggregated the ratings along with the three primary dimensions from the nine clinical reviewers based on a majority vote.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The majority vote of nine physicians accurately reflects the true relevance, evidence quality, and actionability of each response.
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationnone given

    The novelty rate of the questions may differ in other contexts.

    “Additionally, the novelty rate of the questions may differ in other contexts.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Before grading, all reviewers underwent training on the use of the rubric using several case studies.

    “Before grading, all reviewers underwent training on the use of the rubric using several case studies.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductown data

    Novelty of questions was determined by a consensus vote among three independent reviewers who searched the medical literature for keywords from each question.

    “Novelty was determined by a consensus vote among three independent reviewers who searched the medical literature for keywords from each question (Supplemental Table 1).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationnone given

    The overall trends will likely hold.

    “However, the overall trends will likely hold.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Large language models have displayed impressive performance summarizing relevant literature and responding to natural language queries.

    “Large language models have displayed impressive performance summarizing relevant literature14–16 and responding to natural language queries.”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites [14] Sun Y-X Li Z-M Huang J-Z, et al. GPT-4: the future of cosmetic procedure consultation? Aesthet Surg J 2023; 43: NP670– 2. 37154801 source

      Not checked in the free run.

    • cites [15] Chen S Kann BH Foote MB, et al. Use of artificial intelligence chatbots for cancer treatment information. JAMA Oncol 2023; 9: 1459– 1462. 37615976 PMC10450584 source

      Not checked in the free run.

    • cites [16] Goodman RS Patrinely JR Stone CA, et al. Accuracy and reliability of chatbot responses to physician questions. JAMA Netw Open 2023; 6: e2336483. PMC10546234 37782499 source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Study design and conductown data

    Nine physicians across several specialties graded the responses from all five LLM systems using a standardized rubric.

    “Nine physicians across several specialties graded the responses from all five LLM systems using a standardized rubric (Supplemental Table 4).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    OpenEvidence uses an LLM for RAG with different types of medical literature, including PubMed articles and FDA drug labels, to answer clinical questions submitted via the web or its API.

    “OpenEvidence uses an LLM for RAG with different types of medical literature, including PubMed articles and FDA drug labels to answer clinical questions submitted via the web or its API. 28”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [28] OpenEvidence. OpenEvidence AI becomes the first AI in history to score above 90% on the United States Medical Licensing Examination (USMLE) [Internet]. 2023 [cited 2024 Jun 28], https://www.openevidence.com/announcements/openevidence-ai-first-ai-score-above-90-percent-on-the-usmle

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Study design and conductown data

    The validity of citations from ChatGPT, Claude, Gemini, and OpenEvidence was checked before passing responses to clinical reviewers.

    “We checked the validity of these citations before passing the responses on to our clinical reviewers (Clinical Review).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    For general LLMs, citations were verified by determining if the relevant article could be located on PubMed.

    “For the general LLMs, we verified citations by determining if the relevant article could be located on PubMed.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    For OpenEvidence, citations were verified by confirming that each link directed to the appropriate study.

    “Since OpenEvidence provides links for each citation, we were able to verify the citations by confirming that each link directed to the appropriate study.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    As a result, the study focused mainly on questions that lend themselves to comparative effectiveness studies.

    “As a result, this study focused mainly on questions that lend themselves to comparative effectiveness studies.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductown data

    For ChatRWD, two medical informaticists reviewed the phenotypes and TQL code for each PICO element to ensure their appropriateness, grading them incorrect, not ideal but acceptable, or good.

    “For each of the 50 questions, two medical informaticists reviewed the phenotypes and the TQL code for each PICO element to ensure their appropriateness, selecting from one of three grades: incorrect, not ideal but acceptable, good.”
    Quote in the paperSubstantial claim
46 of 46
  • The paper relies on this without support.

    The 50 selected clinical questions are representative of real-world clinical questions encountered in practice.

    “We selected 50 questions (Supplemental Table 1) that were either submitted to Atropos Health by physicians requesting evidence for clinical decisions or inspired by such questions.”
  • The paper relies on this without support.

    The five LLM systems tested are representative of their respective categories (general-purpose LLMs, RAG-based systems, agentic systems).

    “We used three general-purpose LLMs (ChatGPT-4 [2 May 2024], Claude 3 Opus [20240229], and Gemini 1.5 Pro [001]) to produce answers to the selected clinical questions.”
  • The paper relies on this without support.

    The unblinded review did not bias the physicians' ratings of the systems.

    “Because the various LLM systems all have easily identifiable response structures, the physicians were not blinded to the system that generated the answer.”
  • The paper relies on this without support.

    The majority vote of nine physicians accurately reflects the true relevance, evidence quality, and actionability of each response.

    “We first aggregated the ratings along with the three primary dimensions from the nine clinical reviewers based on a majority vote.”
  • The paper relies on this without support.

    General-purpose LLMs are not designed for the complex tasks required for RWE generation (study design classification, PICO extraction, and clinical named-entity recognition).

    “Further, general-purpose LLMs are not designed for the complex tasks required for RWE generation: study design classification, PICO extraction, and clinical named-entity recognition.”
  • The paper relies on this without support.

    An LLM cannot provide responses to novel medical questions whose answer is in content created after the LLM's most recent training completion date.

    “Finally, an LLM cannot provide responses to novel medical questions whose answer is in content created after the LLM's most recent training completion date.”
  • The paper relies on this without support.

    There is a considerable time lag between asking a clinical question and publishing a comparative study to answer the question.

    “However, because there is a considerable time lag between asking a clinical question and publishing a comparative study to answer the question, relying only on past studies is inadequate.”
  • The paper relies on this without support.

    These new studies are motivated by patients with specific preexisting conditions and medications who do not qualify for clinical trials.

    “These new studies are motivated by patients with specific preexisting conditions and medications who do not qualify for clinical trials.”
  • The paper relies on this without support.

    Pertinent evidence remains difficult to obtain for many patient care decisions.

    “Pertinent evidence remains difficult to obtain for many patient care decisions.”
  • The paper relies on this without support.

    Difficulty in contextualizing available studies for the specific intricacies of the patient at hand is a challenge in obtaining evidence.

    “Challenges in obtaining evidence stem from two sources: (1) nearly 80% of care decisions lack high-quality evidence due to no specific study being available 2 and (2) difficulty in contextualizing available studies for the specific intricacies of the patient at hand.”
  • The authors state this as an assumption.

    Many users would not attempt to reprompt the general-purpose LLM after a null answer.

    “We expected that many users would not attempt to reprompt the LLM after such an answer, so did not include that in our study.”
  • The authors state this as an assumption.

    The typical use case for each model is as described (ChatRWD interactive, general-purpose LLMs non-interactive).

    “We chose this approach to mimic what we expected to be the typical use case for each model.”
  • The paper relies on this without support.

    ChatRWD is interactive by nature, so a user would experience the interactive prompting.

    “ChatRWD is interactive by nature, so a user would experience the interactive prompting.”
13 of 13

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A study by Low et al. using 50 clinical questions showed that special-purpose LLMs, including OpenEvidence, consistently outperformed general-purpose models in generating reliable answers.

    “Similarly, a study by Low et al. using 50 clinical questions showed that special-purpose LLMs, including OpenEvidence, consistently outperformed general-purpose models in generating reliable answers [29].”

    From Diagnostic performance of Prof. Valmed, ChatGPT-5 Thinking, and OpenEvidence in rheumatology: A comparative evaluation (2026) · cites this paper as [29]

    The Background and significance section says the study tested 50 clinical questions, and the Results section reports higher rates of relevant, evidence-based answers for OpenEvidence and ChatRWD than for the general-purpose models. However, “consistently outperformed” overstates the pairwise results: OpenEvidence significantly outperformed Gemini, but not the other general-purpose models. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Retrieval-augmented large language models with targeted retrievals and agentic workflows can provide more evidence-grounded and clinically actionable responses to real-world clinical questions than base models alone.

    “Recent work has shown that these LLMs, augmented with targeted retrievals and agentic workflows, can provide more evidence-grounded and therefore clinically actionable responses to real-world clinical questions than base models can alone (Low et al. 2025).”
  • Retrieval-augmented generation grounds model outputs in documents fetched from trusted corpora, reducing the likelihood of factual drift.

    “Reliability can be strengthened further with retrieval-augmented generation (RAG), which grounds model outputs in documents fetched from trusted corpora (e.g., PubMed, guidelines, institutional repositories) [63,64].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Gemini relevance counts conflict with the evidence-quality denominator

    Major

    Table 3 reports that 46.9% of Gemini's 32 generated answers were relevant and 15.6% were partially relevant-20 answers in total. Yet its evidence-quality section uses 30 partially or fully relevant responses as the denominator.

1 of 1

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Dash D Thapa R Banda JM et al. [2304.13714] Evaluation of GPT-3.5 and GPT-4 for supporting real-world information needs in healthcare delivery. arXiv. 2023 Apr 26.

Cited by

Sorted by citations

Authors
Low, Y. S., Jackson, M. L., Hyde, R. J., Brown, R. E., Sanghavi, N. M., Baldwin, J. D., Pike, C. W., Muralidharan, J., Hui, G., Alexander, N., Hassan, H., Nene, R. V., Pike, M., Pokrzywa, C. J., Vedak, S., Yan, A. P., Yao, D.-H., Zipursky, A. R., Dinh, C., Ballentine, P., Derieg, D. C., Polony, V., Chawdry, R. N., Davies, J., Hyde, B. B., Shah, N. H., & Gombar, S.
Affiliations
  • Atropos Health, New York, NY, USA
  • University of California, Los Angeles (US)
  • Hospital for Sick Children (CA)
  • University of California San Diego (US)
  • University of Michigan (US)
  • Columbia University (US)
  • Stanford University (US)
  • Stanford Medicine (US)
Corresponding author
Jackson, Michael L
Venue
DIGITAL HEALTH
Published
2025-05
Volume
11
Pages
20552076251348850-20552076251348850
ISSN
2055-2076 (ISSN-L)
OpenAlex
W4411181503
Cited by
51
References
30
Citations by year
2026: 35 · 2025: 16
FWCI
12.28
Type
journal article
Language
en
Open access
Locations
  • Digital Health (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Atropos Health (Not Applicable)
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
  • Physical Sciences › Computer Science › Information Systems › Information Retrieval and Search Behavior
Keywords
large language models, retrieval-augmented generation, agentic systems, evidence-based medicine, medical question answering, real-world data, OpenEvidence, generative AI in medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review